Feng Wang

6PUBLICATIONS
6CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer diagnosisRheumatology and arthritis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 13, 2025
TsR-0072 inhibits colorectal cancer progression through modulating lipid and vitamin D<sub>3</sub> metabolic reprogramming and inactivating the Wnt/β-catenin signalling pathway.

Qianyi Qi, Bairong Chen, Jinran Wu

|Jul 08, 2025
tRNA-Derived Small RNA Accelerates Tumorigenesis through Crosstalk with Tumor-Associated Macrophages, and Downregulation with Cell Membrane-Modified Polymer Nanoparticles Enables Treatment Response.

Zhou Zhou, Bairong Chen, Jibin Liu

|Jul 06, 2025
Evaluation of serum hsa_tsr014055 as a potential biomarker for diagnosis and prognosis of hepatocellular carcinoma.

Jing Xu, Bairong Chen, Jing Qi

|Jul 03, 2025
Hsa_piR_016975 Is a Novel Target of Nanotherapy that Boosts Hepatoma Progression and Sorafenib Resistance by Abating Maspin/GPX4-Mediated Ferroptosis.

Wei Feng, Jing Xu, Bairong Chen

|Sep 07, 2022
Hsa_circ_0000098 is a novel therapeutic target that promotes hepatocellular carcinoma development and resistance to doxorubicin.

Yi Li, Anqi Wu, Lin Chen

|Jul 15, 2022
Research progress on serological indices and their clinical application in rheumatoid arthritis.

Shuting Meng, Longxiao Jing, Weiwei Zhang

Pageof 1

Frequent Collaborators

1 joint publications

Shuting Meng

1 joint publications

Longxiao Jing

1 joint publications

Weiwei Zhang

1 joint publications

Yefeng Dong